Life ScienceCompany
Edwards Lifesciences - Angiogenesis Program Ownership
Who owns Edwards Lifesciences - Angiogenesis Program?
Edwards Lifesciences - Angiogenesis Program is owned by Sangamo Therapeutics. It was acquired on December 4, 2006.
Edwards Lifesciences - Angiogenesis Program Business Overview
Where is Edwards Lifesciences - Angiogenesis Program headquartered?
Edwards Lifesciences - Angiogenesis Program is headquartered in Irvine, California.
What sector is Edwards Lifesciences - Angiogenesis Program in?
Edwards Lifesciences - Angiogenesis Program is a life science company.
Life Science M&A Summary in 2006
Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2006. The largest life science acquisition in 2006 was Guidant - which was acquired by Boston Scientific for $24.6B.
Join Mergr to view all 120 acquisitions of life science companies in 2006, including 22 acquisitions by private equity firms, and 98 by strategics.